In vivo imaging of molecular-genetic targets for cancer therapy

Cancer Cell

Volumn 3, Issue 4, 2003, Pages 327-332

  Tjuvajev, Juri Gelovani ^a   Blasberg, Ronald G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ERLOTINIB; GEFITINIB; IMATINIB; MESSENGER RNA; PROTEIN TYROSINE KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; GASTROINTESTINAL CARCINOMA; GENE MAPPING; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNOFLUORESCENCE TEST; ISOTOPE LABELING; METASTASIS; MOLECULAR GENETICS; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MEDICINE; PRIORITY JOURNAL; PROTEIN TARGETING; REPORTER GENE; REVIEW; TUMOR VASCULARIZATION; ANIMAL; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC TRANSCRIPTION; MOLECULAR BIOLOGY; NEOPLASM; THREE DIMENSIONAL IMAGING;

ANIMALS; GENE EXPRESSION PROFILING; GENES, REPORTER; GENETIC MARKERS; HUMANS; IMAGING, THREE-DIMENSIONAL; MOLECULAR BIOLOGY; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 1542509657     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00082-5     Document Type: Review

References (31)

1. Blasberg R., Gelovani Tjuvajev J. Molecular imaging: A nuclear based perspective. Mol. Imaging. 1:2002;160-180.
2. Blasberg R., Gelovani J. Molecular-Genetic Imaging: Current and Future Prespectives. J. Clin. Invest. in press:2003.
3. Contag C.H., Ross B.D. It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J. Magn. Reson. Imaging. 16:2002;378-387.
4. Demetri G.D., von Mehren M., Blanke C.D., Van den Abbeele A.D., Eisenberg B., Roberts P.J., Heinrich M.C., Tuveson D.A., Singer S., Janicek M., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347:2002;472-480.
5. Doubrovin M., Ponomarev V., Beresten T., Balatoni J., Bornmann W., Finn R., Humm J., Larson S., Sadelain M., Blasberg R., Gelovani Tjuvajev J. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc. Natl. Acad. Sci. USA. 98:2001;9300-9305.
6. Dubey P., Su H., Adonai N., Du S., Rosato A., Braun J., Gambhir S.S., Witte O.N. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc. Natl. Acad. Sci. USA. 100:2003;1232-1237.
7. Edinger M., Cao Y.A., Hornig Y.S., Jenkins D.E., Verneris M.R., Bachmann M.H., Negrin R.S., Contag C.H. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur. J. Cancer. 38:2002;2128-2136.
8. Gambhir S.S., Bauer E., Black M.E., Liang Q., Kokoris M.S., Barrio J.R., Iyer M., Namavari M., Phelps M.E., Herschman H.R. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc. Natl. Acad. Sci. USA. 97:2000;2785-2790.
9. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer. 2:2002;683-693.
10. Hadjantonakis A.K., Macmaster S., Nagy A. Embryonic stem cells and mice expressing different GFP variants for multiple non-invasive reporter usage within a single animal. BMC Biotechnol. 2:2002;11-20.
11. Haubner R., Wester H.J., Weber W.A., Mang C., Ziegler S.I., Goodman S.L., Senekowitsch-Schmidtke R., Kessler H., Schwaiger M. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 61:2001;1781-1785.
12. Ichikawa T., Hogemann D., Saeki Y., Tyminski E., Terada K., Weissleder R., Chiocca E.A., Basilion J.P. MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia. 4:2002;523-530.
13. Iyer M., Wu L., Carey M., Wang Y., Smallwood A., Gambhir S.S. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc. Natl. Acad. Sci. USA. 98:2001;14595-14600.
14. Jacobs A., Voges J., Reszka R., Lercher M., Gossmann A., Kracht L., Kaestle C., Wagner R., Wienhard K., Heiss W.D. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 358:2001;727-729.
15. Jaffer F.A., Tung C.H., Gerszten R.E., Weissleder R. In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler. Thromb. Vasc. Biol. 22:2002;1929-1935.
16. Koehne G., Doubrovin M., Doubrovina E., Zanzonico P., Gallardo H., Ivanova A., Balatoni J., Teruya-Feldstein J., Heller G., May C., et al. Short and long-term in vivo imaging of targeted migration of HSV-TK transduced human antigen-specific lymphocyets. Nat. Biotechnol. 21:2003;405-413.
17. Luker G.D., Sharma V., Pica C.M., Dahlheimer J.L., Li W., Ochesky J., Ryan C.E., Piwnica-Worms H., Piwnica-Worms D. Noninvasive imaging of protein-protein interactions in living animals. Proc. Natl. Acad. Sci. USA. 99:2002;6961-6966.
18. Mandl S., Schimmelpfennig C., Edinger M., Negrin R.S., Contag C.H. Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. J. Cell. Biochem. Suppl. 39:2002;239-248.
19. Mayer-Kuckuk P., Banerjee D., Malhotra S., Doubrovin M., Iwamoto M., Akhurst T., Balatoni J., Bornmann W., Finn R., Larson S., et al. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression. Proc. Natl. Acad. Sci. USA. 99:2002;3400-3405.
20. Ortu G., Ben-David I., Rozen Y., Freedman N.M., Chisin R., Levitzki A., Mishani E. Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug. Int. J. Cancer. 101:2002;360-370.
21. Perez J.M., Josephson L., O'Loughlin T., Hogemann D., Weissleder R. Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20:2002;816-820.
22. Ponomarev V., Doubrovin M., Lyddane C., Beresten T., Balatoni J., Bornman W., Finn R., Akhurst T., Larson S., Blasberg R., et al. Imaging TCR-Dependent NFAT-Mediated T-Cell Activation with Positron Emission Tomography In Vivo. Neoplasia. 3:2001;480-488.
23. Qiao J., Doubrovin M., Sauter M.V., Huang Y., Guo Z.S., Balatoni J., Akhurst T., Blasberg R., Gelovani Tjuvajev J., Chen S.H., Woo S.L.C. Tumor-Specific Transcriptional Targeting of Suicide Gene Therapy. Gene Ther. 9:2002;168-175.
24. Ray P., Pimenta H., Paulmurugan R., Berger F., Phelps M.E., Iyer M., Gambhir S.S. Non-invasive quantitative imaging of protein-protein interactions in living subjects. Proc. Natl. Acad. Sci. USA. 99:2002;3105-3110.
25. 131I]-iododeoxyuridine. J. Nucl. Med. 35:1994;1407-1417.
26. Tjuvajev J.G., Stockhammer G., Desai R., Uehara H., Watanabe H., Gansbacher B., Blasberg R.G. Imaging the expression of transfected genes in vivo. Cancer Res. 55:1995;6126-6132.
27. Tjuvajev J.G., Avril N., Oku T., Sasajima T., Miyagawa T., Joshi R., Safer M., Beattie B., DiResta G., Daghighian F., et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58:1998;4333-4341.
28. Vooijs M., Jonkers J., Lyons S., Berns A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res. 62:2002;1862-1867.
29. Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat. Rev. Cancer. 2:2002;11-18.
30. Weissleder R., Ntziachristos V. Shedding light onto live molecular targets. Nat. Med. 9:2003;123-128.
31. Zhao M., Kircher M.F., Josephson L., Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug. Chem. 13:2002;840-844.